TrialsgrambetaRCTs are beautiful

CAMERA2

2020

Combination Antibiotic Therapy for MRSA Bacteraemia

In 352 patients with MRSA bacteraemia, standard therapy plus an anti-staphylococcal β-lactam did not improve a composite of mortality, persistent bacteraemia and relapse versus standard therapy alone and acute kidney injury increased.

Result

Composite of mortality, persistent bacteraemia, relapse or treatment failure
Absolute difference
4 points
Effect estimate

absolute difference-4.295% CI -14.3 to 6.0

The absolute difference is derived from the event rates.

Also reported: Acute kidney injury 23% vs 6%.

Original publication
Subtopic
MRSA bacteraemia
Design
Open-label RCT, stopped early for safety
Relevance
Important: one of several pillars.
Source
Tong SYC, et al. JAMA. 2020;323(6):527-537.doi 10.1001/jama.2020.0103

Discussion & critique

Routine upfront β-lactam combination is harmful in MRSA bacteraemia without benefit; vancomycin or daptomycin monotherapy remains standard.

Discussed in podcasts